Spence McClelland joined Noro-Moseley Partners in 2010 and supports the firm’s investments in healthcare and tech-enabled services. Spence enjoys working with portfolio company management teams to develop and execute their strategic plans. He currently represents NMP on the boards of Contessa Health, Envera Health, LogicStream and Pure Life Renal and serves as a board observer for GetInsured and Novu. He was previously on the board of Change Healthcare (sold to Emdeon Inc. in 2014) and Hospicelink (sold to Blue Wolf Capital in 2018). Prior to joining NMP, Spence worked in the corporate development group of Healthways, Inc., was an associate with the private equity firm Willis Stein & Partners, and also worked in the investment banking groups of J.C. Bradford and DLJ. Spence received a BA from Vanderbilt University and an MBA from the Kellogg School of Management at Northwestern University.
Board of Directors